These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 37088815

  • 1. Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age.
    Guo Z, Jin F, Chen S, Hu P, Hao Y, Yu Q.
    BMC Endocr Disord; 2023 Apr 23; 23(1):89. PubMed ID: 37088815
    [Abstract] [Full Text] [Related]

  • 2. Correlation of clinical and biochemical hyperandrogenism in Thai women with polycystic ovary syndrome.
    Leerasiri P, Wongwananuruk T, Indhavivadhana S, Techatraisak K, Rattanachaiyanont M, Angsuwathana S.
    J Obstet Gynaecol Res; 2016 Jun 23; 42(6):678-83. PubMed ID: 26890011
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W.
    J Cosmet Dermatol; 2018 Jun 23; 17(3):511-517. PubMed ID: 28940857
    [Abstract] [Full Text] [Related]

  • 4. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, Lee J, Zane LT, Shinkai K.
    JAMA Dermatol; 2016 Apr 23; 152(4):391-8. PubMed ID: 26720591
    [Abstract] [Full Text] [Related]

  • 5. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, Morselli Labate AM, Repaci A, Ribichini D, Gambineri A.
    J Clin Endocrinol Metab; 2016 May 23; 101(5):2013-22. PubMed ID: 26964728
    [Abstract] [Full Text] [Related]

  • 6. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y, Ouyang N, Ye Y, Hu Q, Du T, Di N, Xu W, Azziz R, Yang D, Zhao X.
    Reprod Biomed Online; 2020 Oct 23; 41(4):734-742. PubMed ID: 32912651
    [Abstract] [Full Text] [Related]

  • 7. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome.
    Franik G, Bizoń A, Włoch S, Kowalczyk K, Biernacka-Bartnik A, Madej P.
    Eur Rev Med Pharmacol Sci; 2018 Jul 23; 22(14):4411-4418. PubMed ID: 30058676
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F, Chen M, Zhang W, Yin H, Chen G, Huang Q, Yang X, Chen L, Lin C, Yin G.
    J Ovarian Res; 2021 Feb 14; 14(1):32. PubMed ID: 33583431
    [Abstract] [Full Text] [Related]

  • 9. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis.
    Amiri M, Ramezani Tehrani F, Nahidi F, Bidhendi Yarandi R, Behboudi-Gandevani S, Azizi F.
    Clin Endocrinol (Oxf); 2017 Sep 14; 87(3):217-230. PubMed ID: 28575537
    [Abstract] [Full Text] [Related]

  • 10. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan 14; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 11. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
    Hacivelioglu S, Gungor AN, Gencer M, Uysal A, Hizli D, Koc E, Cosar E.
    Int J Gynaecol Obstet; 2013 Oct 14; 123(1):33-6. PubMed ID: 23948280
    [Abstract] [Full Text] [Related]

  • 12. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A, Pazderska A, Ahmed M, McGowan A, Phelan N, Boran G, Taylor AE, O'Reilly MW, Arlt W, Moore K, Behan LA, Sherlock M, Gibney J.
    Hum Reprod; 2018 Sep 01; 33(9):1727-1734. PubMed ID: 30020477
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome.
    Hahn S, Kuehnel W, Tan S, Kramer K, Schmidt M, Roesler S, Kimmig R, Mann K, Janssen OE.
    Clin Chem Lab Med; 2007 Sep 01; 45(2):202-7. PubMed ID: 17311509
    [Abstract] [Full Text] [Related]

  • 14. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
    Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C.
    Eur J Endocrinol; 2006 Dec 01; 155(6):859-65. PubMed ID: 17132756
    [Abstract] [Full Text] [Related]

  • 15. Correlation of biochemical markers and clinical signs of hyperandrogenism in women with polycystic ovary syndrome (PCOS) and women with non-classic congenital adrenal hyperplasia (NCAH).
    Chanukvadze D, Kristesashvili J, Kvashilava N.
    Iran J Reprod Med; 2012 Jul 01; 10(4):307-14. PubMed ID: 25246891
    [Abstract] [Full Text] [Related]

  • 16. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, American Association of Clinical Endocrinologists (AACE), American College of Endocrinology (ACE), Androgen Excess and PCOS Society (AES).
    Endocr Pract; 2015 Nov 01; 21(11):1291-300. PubMed ID: 26509855
    [Abstract] [Full Text] [Related]

  • 17. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40.
    Liang SJ, Hsu CS, Tzeng CR, Chen CH, Hsu MI.
    Hum Reprod; 2011 Dec 01; 26(12):3443-9. PubMed ID: 21926412
    [Abstract] [Full Text] [Related]

  • 18. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.
    Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.
    Arch Gynecol Obstet; 2013 Mar 01; 287(3):525-31. PubMed ID: 23108387
    [Abstract] [Full Text] [Related]

  • 19. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D, Škrgatić L, Bukvić Mokos Z, Trgovčić I.
    Acta Dermatovenerol Croat; 2013 Mar 01; 21(2):105-12. PubMed ID: 24001418
    [Abstract] [Full Text] [Related]

  • 20. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul 01; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.